Market closed
Armata Pharmaceuticals/$ARMP
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Armata Pharmaceuticals
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.
Ticker
$ARMP
Sector
Trading on
AMEX
Industry
Biotechnology
Headquarters
Employees
60
Website
ARMP Metrics
BasicAdvanced
$49M
-
-$0.89
0.90
-
Price and volume
Market cap
$49M
Beta
0.9
52-week high
$3.45
52-week low
$0.90
Average daily volume
22K
Financial strength
Current ratio
0.234
Quick ratio
0.208
Long term debt to equity
-173.119
Total debt to equity
-263.469
Interest coverage (TTM)
-3.95%
Management effectiveness
Return on assets (TTM)
-28.70%
Return on equity (TTM)
47.24%
Valuation
Price to revenue (TTM)
9.448
Price to book
-1.02
Price to tangible book (TTM)
-0.79
Price to free cash flow (TTM)
-1.24
Growth
Revenue change (TTM)
14.24%
Earnings per share change (TTM)
-53.57%
3-year revenue growth (CAGR)
4.96%
3-year earnings per share growth (CAGR)
-2.56%
What the Analysts think about ARMP
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Armata Pharmaceuticals stock.
ARMP Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
ARMP Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Armata Pharmaceuticals stock?
Armata Pharmaceuticals (ARMP) has a market cap of $49M as of April 25, 2025.
What is the P/E ratio for Armata Pharmaceuticals stock?
The price to earnings (P/E) ratio for Armata Pharmaceuticals (ARMP) stock is 0 as of April 25, 2025.
Does Armata Pharmaceuticals stock pay dividends?
No, Armata Pharmaceuticals (ARMP) stock does not pay dividends to its shareholders as of April 25, 2025.
When is the next Armata Pharmaceuticals dividend payment date?
Armata Pharmaceuticals (ARMP) stock does not pay dividends to its shareholders.
What is the beta indicator for Armata Pharmaceuticals?
Armata Pharmaceuticals (ARMP) has a beta rating of 0.9. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.